Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 30

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 3
Chunk 30
---
 price
information with respect to the “penny stock” held in a customer’s account and information with respect to the limited
market in “penny stocks”.

Securities
holders should be aware that, according to the SEC, the market for “penny stocks” has suffered in recent years from patterns
of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related
to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press
releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced
sales persons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping
of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, resulting in investor losses.

If
securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they
adversely change their recommendations or publish negative reports regarding our business or our shares, our ADSs or ordinary shares
price and trading volume could decline.

The trading market for our ADSs or our ordinary shares will be influenced
by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors. We
do not have any control over these analysts and we cannot provide any assurance that analysts will cover us or provide favorable coverage.
If any of the analysts who may cover us adversely change their recommendation regarding our ADSs or ordinary shares, or provide more favorable
relative recommendations about our competitors, our ADSs or ordinary shares price would likely decline. If any analyst who may cover us
were to cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which
in turn could cause our ADSs or ordinary shares price or trading volume to decline.

Sales
of a substantial number of ADSs representing our ordinary shares in the public market by our existing shareholders could cause our share
price to fall.

Sales
of a substantial number of ADSs representing our ordinary shares in the public market, or the perception that these sales might occur,
could depress the market price of our ADSs and could impair our ability to raise capital through the sale of additional equity securities.
We are unable to predict the effect that sales